The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lymphoma, Large-Cell, Diffuse

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lymphoma, Large-Cell, Diffuse


High impact information on Lymphoma, Large-Cell, Diffuse


Chemical compound and disease context of Lymphoma, Large-Cell, Diffuse


Biological context of Lymphoma, Large-Cell, Diffuse


Anatomical context of Lymphoma, Large-Cell, Diffuse


Gene context of Lymphoma, Large-Cell, Diffuse


Analytical, diagnostic and therapeutic context of Lymphoma, Large-Cell, Diffuse


  1. Advanced diffuse histiocytic lymphoma, a potentially curable disease. DeVita, V.T., Canellos, G.P., Chabner, B., Schein, P., Hubbard, S.P., Young, R.C. Lancet (1975) [Pubmed]
  2. VH gene analysis of primary cutaneous B-cell lymphomas: evidence for ongoing somatic hypermutation and isotype switching. Aarts, W.M., Willemze, R., Bende, R.J., Meijer, C.J., Pals, S.T., van Noesel, C.J. Blood (1998) [Pubmed]
  3. BCL-6 protein is expressed in germinal-center B cells. Cattoretti, G., Chang, C.C., Cechova, K., Zhang, J., Ye, B.H., Falini, B., Louie, D.C., Offit, K., Chaganti, R.S., Dalla-Favera, R. Blood (1995) [Pubmed]
  4. Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging. Bergan, R., Hakim, F., Schwartz, G.N., Kyle, E., Cepada, R., Szabo, J.M., Fowler, D., Gress, R., Neckers, L. Blood (1996) [Pubmed]
  5. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene. Akasaka, T., Akasaka, H., Ueda, C., Yonetani, N., Maesako, Y., Shimizu, A., Yamabe, H., Fukuhara, S., Uchiyama, T., Ohno, H. J. Clin. Oncol. (2000) [Pubmed]
  6. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Dent, A.L., Shaffer, A.L., Yu, X., Allman, D., Staudt, L.M. Science (1997) [Pubmed]
  7. Diffuse histiocytic lymphoma. The need for aggressive restaging. Weinerman, B.H., Levitt, M., Babick, T. JAMA (1977) [Pubmed]
  8. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. Pasqualucci, L., Compagno, M., Houldsworth, J., Monti, S., Grunn, A., Nandula, S.V., Aster, J.C., Murty, V.V., Shipp, M.A., Dalla-Favera, R. J. Exp. Med. (2006) [Pubmed]
  9. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Present, D.H., Meltzer, S.J., Krumholz, M.P., Wolke, A., Korelitz, B.I. Ann. Intern. Med. (1989) [Pubmed]
  10. Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Shipp, M.A., Harrington, D.P., Klatt, M.M., Jochelson, M.S., Pinkus, G.S., Marshall, J.L., Rosenthal, D.S., Skarin, A.T., Canellos, G.P. Ann. Intern. Med. (1986) [Pubmed]
  11. Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study. Miller, T.P., Dahlberg, S., Weick, J.K., Files, J.C., Eyre, H.J., Pendergrass, K.B., Fisher, R.I. J. Clin. Oncol. (1990) [Pubmed]
  12. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution. Gaynor, E.R., Ultmann, J.E., Golomb, H.M., Sweet, D.L. J. Clin. Oncol. (1985) [Pubmed]
  13. Urinary excretion of monoacetyl polyamines in patients with non-Hodgkin's lymphoma. Abdel-Monem, M.M., Merdink, J.L., Theologides, A. Cancer Res. (1982) [Pubmed]
  14. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors. Epstein, A.L., Marder, R.J., Winter, J.N., Fox, R.I. J. Immunol. (1984) [Pubmed]
  15. Epstein-Barr virus-induced lymphoma in a cardiac transplant recipient. Dummer, J.S., Bound, L.M., Singh, G., Atchison, R.W., Kapadia, S.B., Ho, M. Am. J. Med. (1984) [Pubmed]
  16. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Chang, C.C., Ye, B.H., Chaganti, R.S., Dalla-Favera, R. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  17. Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B.H., Knowles, D.M., Offit, K., Chaganti, R.S., Dalla-Favera, R. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  18. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Lu, X., Nechushtan, H., Ding, F., Rosado, M.F., Singal, R., Alizadeh, A.A., Lossos, I.S. Blood (2005) [Pubmed]
  19. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Flenghi, L., Ye, B.H., Fizzotti, M., Bigerna, B., Cattoretti, G., Venturi, S., Pacini, R., Pileri, S., Lo Coco, F., Pescarmona, E. Am. J. Pathol. (1995) [Pubmed]
  20. Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma. Kumar, A., Mandiyan, V., Suzuki, Y., Zhang, C., Rice, J., Tsai, J., Artis, D.R., Ibrahim, P., Bremer, R. J. Mol. Biol. (2005) [Pubmed]
  21. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Capello, D., Vitolo, U., Pasqualucci, L., Quattrone, S., Migliaretti, G., Fassone, L., Ariatti, C., Vivenza, D., Gloghini, A., Pastore, C., Lanza, C., Nomdedeu, J., Botto, B., Freilone, R., Buonaiuto, D., Zagonel, V., Gallo, E., Palestro, G., Saglio, G., Dalla-Favera, R., Carbone, A., Gaidano, G. Blood (2000) [Pubmed]
  22. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Iida, S., Rao, P.H., Nallasivam, P., Hibshoosh, H., Butler, M., Louie, D.C., Dyomin, V., Ohno, H., Chaganti, R.S., Dalla-Favera, R. Blood (1996) [Pubmed]
  23. Monoclonal antibody studies in non-Hodgkin's lymphoma. Aisenberg, A.C., Wilkes, B.M., Harris, N.L. Blood (1983) [Pubmed]
  24. Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course. Lippman, S.M., Spier, C.M., Miller, T.P., Slymen, D.J., Rybski, J.A., Grogan, T.M. Mod. Pathol. (1990) [Pubmed]
  25. Fatal veno-occlusive disease of the liver following high-dose 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and autologous bone marrow transplantation. McIntyre, R.E., Magidson, J.G., Austin, G.E., Gale, R.P. Am. J. Clin. Pathol. (1981) [Pubmed]
  26. BCL8, a novel gene involved in translocations affecting band 15q11-13 in diffuse large-cell lymphoma. Dyomin, V.G., Rao, P.H., Dalla-Favera, R., Chaganti, R.S. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  27. Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma. Vyth-Dreese, F.A., Boot, H., Dellemijn, T.A., Majoor, D.M., Oomen, L.C., Laman, J.D., Van Meurs, M., De Weger, R.A., De Jong, D. Immunology (1998) [Pubmed]
  28. Histological progression of follicular lymphoma associated with p53 mutation and rearrangement of the C-MYC gene. Takimoto, Y., Takafuta, T., Imanaka, F., Kuramoto, A., Sasaki, N., Nanba, K. Hiroshima J. Med. Sci. (1996) [Pubmed]
  29. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. Plumas, J., Jacob, M.C., Chaperot, L., Molens, J.P., Sotto, J.J., Bensa, J.C. Blood (1998) [Pubmed]
  30. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Downing, J.R., Shurtleff, S.A., Zielenska, M., Curcio-Brint, A.M., Behm, F.G., Head, D.R., Sandlund, J.T., Weisenburger, D.D., Kossakowska, A.E., Thorner, P. Blood (1995) [Pubmed]
  31. Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis. Cortes, J.E., Talpaz, M., Cabanillas, F., Seymour, J.F., Kurzrock, R. Blood (1995) [Pubmed]
  32. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B. Lee, A.Y., Connors, J.M., Klimo, P., O'Reilly, S.E., Gascoyne, R.D. J. Clin. Oncol. (1997) [Pubmed]
  33. The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma. Maki, A., Diwakaran, H., Redman, B., al-Asfar, S., Pettit, G.R., Mohammad, R.M., al-Katib, A. Anticancer Drugs (1995) [Pubmed]
  34. Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma. Avilés, A., Zepeda, G., Díaz-Maqueo, J.C., Rodriguez, L., Guzmán, R., García, E.L., Talavera, A. Leuk. Lymphoma (1992) [Pubmed]
  35. bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features. Jacobson, J.O., Wilkes, B.M., Kwaiatkowski, D.J., Medeiros, L.J., Aisenberg, A.C., Harris, N.L. Cancer (1993) [Pubmed]
WikiGenes - Universities